Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
Uveal melanoma is considered a rare disease but it is the most common intraocular malignancy in adults. Local treatments are effective, but the systemic recurrence rate is unacceptably high. Moreover, once metastasis have developed the prognosis is poor, with a 5-year survival rate of less than 5%,...
| Authors: | ; ; ; ; ; ; |
|---|---|
| Format: | Article |
| Status: | Published version |
| Publication date: | 2019 |
| Country: | España |
| Institution: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repository: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/174839 |
| Online Access: | https://hdl.handle.net/2445/174839 |
| Access Level: | Open access |
| Keyword: | Melanoma Oftalmopaties Angiogènesi Immunoteràpia Ophthalmopathies Neovascularization Immunotherapy |
| _version_ | 1878739277800538112 |
|---|---|
| author | Castet, Florian |
| author2 | García Mulero, Sandra Sanz Pamplona, Rebeca Cuellar, Andres Casanovas i Casanovas, Oriol Caminal Mitjana, Josep Maria Piulats, Josep M. |
| author2_role | author author author author author author |
| author_browse | Caminal Mitjana, Josep Maria Casanovas i Casanovas, Oriol Castet, Florian Cuellar, Andres García Mulero, Sandra Piulats, Josep M. Sanz Pamplona, Rebeca |
| author_facet | Castet, Florian García Mulero, Sandra Sanz Pamplona, Rebeca Cuellar, Andres Casanovas i Casanovas, Oriol Caminal Mitjana, Josep Maria Piulats, Josep M. |
| author_role | author |
| collection | Recercat. Dipósit de la Recerca de Catalunya |
| description | Uveal melanoma is considered a rare disease but it is the most common intraocular malignancy in adults. Local treatments are effective, but the systemic recurrence rate is unacceptably high. Moreover, once metastasis have developed the prognosis is poor, with a 5-year survival rate of less than 5%, and systemic therapies, including immunotherapy, have rendered poor results. The tumour biology is complex, but angiogenesis is a highly important pathway in these tumours. Vasculogenic mimicry, the ability of melanomas to generate vascular channels independently of endothelial cells, could play an important role, but no effective therapy targeting this process has been developed so far. Angiogenesis modulates the tumour microenvironment of melanomas, and a close interplay is established between them. Therefore, combining immune strategies with drugs targeting angiogenesis offers a new therapeutic paradigm. In preclinical studies, these approaches effectively target these tumours, and a phase I clinical study has shown encouraging results in cutaneous melanomas. In this review, we will discuss the importance of angiogenesis in uveal melanoma, with a special focus on vasculogenic mimicry, and describe the interplay between angiogenesis and the tumour microenvironment. In addition, we will suggest future therapeutic approaches based on these observations and mention ways in which to potentially enhance current treatments. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | ES_be72e028ddd5fc39d64d55fcda0d124c |
| institution | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| instname_str | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| network_acronym_str | ES |
| network_name_str | España |
| oai_identifier_str | oai:recercat.cat:2445/174839 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | MDPI |
| publisherStr | MDPI |
| reponame_str | Recercat. Dipósit de la Recerca de Catalunya |
| spelling | Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? Castet, Florian García Mulero, Sandra Sanz Pamplona, Rebeca Cuellar, Andres Casanovas i Casanovas, Oriol Caminal Mitjana, Josep Maria Piulats, Josep M. Melanoma Oftalmopaties Angiogènesi Immunoteràpia Ophthalmopathies Neovascularization Immunotherapy Uveal melanoma is considered a rare disease but it is the most common intraocular malignancy in adults. Local treatments are effective, but the systemic recurrence rate is unacceptably high. Moreover, once metastasis have developed the prognosis is poor, with a 5-year survival rate of less than 5%, and systemic therapies, including immunotherapy, have rendered poor results. The tumour biology is complex, but angiogenesis is a highly important pathway in these tumours. Vasculogenic mimicry, the ability of melanomas to generate vascular channels independently of endothelial cells, could play an important role, but no effective therapy targeting this process has been developed so far. Angiogenesis modulates the tumour microenvironment of melanomas, and a close interplay is established between them. Therefore, combining immune strategies with drugs targeting angiogenesis offers a new therapeutic paradigm. In preclinical studies, these approaches effectively target these tumours, and a phase I clinical study has shown encouraging results in cutaneous melanomas. In this review, we will discuss the importance of angiogenesis in uveal melanoma, with a special focus on vasculogenic mimicry, and describe the interplay between angiogenesis and the tumour microenvironment. In addition, we will suggest future therapeutic approaches based on these observations and mention ways in which to potentially enhance current treatments. MDPI https://hdl.handle.net/2445/174839 |
| spellingShingle | Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? Castet, Florian Melanoma Oftalmopaties Angiogènesi Immunoteràpia Ophthalmopathies Neovascularization Immunotherapy |
| status_str | publishedVersion |
| title | Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? |
| title_full | Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? |
| title_fullStr | Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? |
| title_full_unstemmed | Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? |
| title_short | Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? |
| title_sort | Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? |
| topic | Melanoma Oftalmopaties Angiogènesi Immunoteràpia Ophthalmopathies Neovascularization Immunotherapy |
| topic_facet | Melanoma Oftalmopaties Angiogènesi Immunoteràpia Ophthalmopathies Neovascularization Immunotherapy |
| url | https://hdl.handle.net/2445/174839 |